Literature DB >> 9891593

Is the failing heart energy depleted?

A M Katz1.   

Abstract

This article takes three different approaches to the question of whether the failing heart is in an energy-starved state. A brief historical overview introduces the issue and points out problems in both models and methods. Second, current information regarding the energetic state of the failing heart is examined. Finally, the mechanistic and therapeutic implications of a defect in energy production are described.

Mesh:

Substances:

Year:  1998        PMID: 9891593     DOI: 10.1016/s0733-8651(05)70040-0

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  25 in total

1.  Impaired ATP kinetics in failing in vivo mouse heart.

Authors:  Ashish Gupta; Vadappuram P Chacko; Michael Schär; Ashwin Akki; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2010-10-06       Impact factor: 7.792

2.  Responses of hypertrophied myocytes to reactive species: implications for glycolysis and electrophile metabolism.

Authors:  Brian E Sansbury; Daniel W Riggs; Robert E Brainard; Joshua K Salabei; Steven P Jones; Bradford G Hill
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

Review 3.  Mitochondrial centrality in heart failure.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2008-01-05       Impact factor: 4.214

4.  Novel strategy for measuring creatine kinase reaction rate in the in vivo heart.

Authors:  Qiang Xiong; Qinglu Li; Abdul Mansoor; Mohammad Nurulqadr Jameel; Fei Du; Wei Chen; Jianyi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

5.  Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.

Authors:  Glenn A Hirsch; Paul A Bottomley; Gary Gerstenblith; Robert G Weiss
Journal:  J Am Coll Cardiol       Date:  2012-02-28       Impact factor: 24.094

6.  Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy.

Authors:  Marvin W Kronenberg; Gerald I Cohen; Marlo F Leonen; Thomas A Mladsi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

7.  Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death.

Authors:  Paul A Bottomley; Gurusher S Panjrath; Shenghan Lai; Glenn A Hirsch; Katherine Wu; Samer S Najjar; Angela Steinberg; Gary Gerstenblith; Robert G Weiss
Journal:  Sci Transl Med       Date:  2013-12-11       Impact factor: 17.956

8.  Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved.

Authors:  Ashish Gupta; Ashwin Akki; Yibin Wang; Michelle K Leppo; V P Chacko; D Brian Foster; Viviane Caceres; Sa Shi; Jonathan A Kirk; Jason Su; Shenghan Lai; Nazareno Paolocci; Charles Steenbergen; Gary Gerstenblith; Robert G Weiss
Journal:  J Clin Invest       Date:  2011-12-27       Impact factor: 14.808

9.  Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation.

Authors:  James J Kohler; Seyed H Hosseini; Ioan Cucoranu; Amy Hoying-Brandt; Elgin Green; David Johnson; Bree Wittich; Jaya Srivastava; Kristopher Ivey; Earl Fields; Rodney Russ; C Michael Raper; Robert Santoianni; William Lewis
Journal:  Lab Invest       Date:  2008-12-15       Impact factor: 5.662

Review 10.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.